Prevalence and Risk Factors for Overweight and Obesity Among HIV-Infected Adults in Dar Es Salaam, Tanzania

Overview

Journal J Int Assoc Provid AIDS Care

Publisher Sage Publications

Specialty Infectious Diseases

Date 2014 Aug 23

PMID 25146972

Citations 22

Authors

Helen Semu

Rachel M Zack

Enju Liu

Ellen Hertzmark

Donna Spiegelman

Kevin Sztam

Claudia Hawkins

Guerino Chalamila

Aisa Muya

Hellen Siril

Ramadhani Mwiru

Deo Mtasiwa

Wafaie Fawzi

Affiliations

Soon will be listed here.

Abstract

Background: Overweight and obesity are increasingly prevalent among HIV-infected populations. We describe their prevalence and associated risk factors among HIV-infected adults in Dar es Salaam, Tanzania.

Methods: A cross-sectional study was conducted to determine the proportion of patients who were overweight or obese at enrollment to care and treatment centres from 2004 to 2011. Multivariate relative risk regression models were fit to identify risk factors.

Results: A total of 53 825 patients were included in the analysis. In all, 16% of women and 8% of men were overweight, while 7% and 2% were obese, respectively. In multivariate analyses, older age, higher CD4 count, higher hemoglobin levels, female sex, and being married were associated with obesity and overweight. World Health Organization HIV disease stage, tuberculosis history, and previous antiretroviral therapy were inversely associated with obesity and overweight.

Conclusion: Overweight and obesity were highly prevalent among HIV-infected patients. Screening for overweight and obesity and focused interventions should be integrated into HIV care.

Citing Articles

Overweight and Obesity Among People Living With HIV on Dolutegravir- and Efavirenz-Based Therapies: A Comparative Cross-Sectional Study.

Jemal M, Adugna A, Getinet M, Baylie T, Waritu N AIDS Res Treat. 2024; 2024:5347620.

PMID: 39735593 PMC: 11671659. DOI: 10.1155/arat/5347620.

Bone Loss and Fractures in Post-Menopausal Women Living with HIV: A Narrative Review.

Jamshaid M, Heidari A, Hassan A, Mital D, Pearce O, Panourgia M Pathogens. 2024; 13(9).

PMID: 39339002 PMC: 11435029. DOI: 10.3390/pathogens13090811.

Trends in body mass index for people with and without HIV: Pooled analysis of nationally-representative health surveys from 10 countries and 173,800 adults in Africa.

Carrillo-Larco R, Bulstra C, Manne-Goehler J, Siedner M, Johnson L, Marconi V PLOS Glob Public Health. 2024; 4(9):e0003640.

PMID: 39288136 PMC: 11407641. DOI: 10.1371/journal.pgph.0003640.

Five-Year Outcomes of Bariatric Surgery vs. Conservative Weight Management in People with HIV: A Single-Center Tertiary Care Experience.

Fehervari M, Mitra A, Sargsyan N, Davison N, Turner M, Efthimiou E Obes Surg. 2024; 34(10):3594-3605.

PMID: 39191979 PMC: 11481672. DOI: 10.1007/s11695-024-07443-7.

Lack of Association of Vascular Risk Factors with HIV-Associated Neurocognitive Disorders in cART-Treated Adults Aged ≥ 50 Years in Tanzania.

Flack K, Rainey E, Urasa S, Koipapi S, Kalaria R, Howlett W Viruses. 2024; 16(6).

PMID: 38932112 PMC: 11209468. DOI: 10.3390/v16060819.

References

Grinspoon S . Insulin resistance in the HIV-lipodystrophy syndrome. Trends Endocrinol Metab. 2001; 12(9):413-9. DOI: 10.1016/s1043-2760(01)00472-6. View

Popkin B . The nutrition transition and obesity in the developing world. J Nutr. 2001; 131(3):871S-873S. DOI: 10.1093/jn/131.3.871S. View

Franssen R, Monajemi H, Stroes E, Kastelein J . Obesity and dyslipidemia. Endocrinol Metab Clin North Am. 2008; 37(3):623-33, viii. DOI: 10.1016/j.ecl.2008.06.003. View

Kroll A, Sprinz E, Leal S, Labrea M, Setubal S . Prevalence of obesity and cardiovascular risk in patients with HIV/AIDS in Porto Alegre, Brazil. Arq Bras Endocrinol Metabol. 2012; 56(2):137-41. DOI: 10.1590/s0004-27302012000200007. View

Cornell M . Gender inequality: Bad for men's health. South Afr J HIV Med. 2013; 14(1):12-14. PMC: 3782744. DOI: 10.7196/SAJHIVMED.894. View

Govindarajulu U, Spiegelman D, Thurston S, Ganguli B, Eisen E . Comparing smoothing techniques in Cox models for exposure-response relationships. Stat Med. 2007; 26(20):3735-52. DOI: 10.1002/sim.2848. View

Amorosa V, Synnestvedt M, Gross R, Friedman H, MacGregor R, Gudonis D . A tale of 2 epidemics: the intersection between obesity and HIV infection in Philadelphia. J Acquir Immune Defic Syndr. 2005; 39(5):557-61. View

Nyaruhucha C, Achen J, Msuya J, Shayo N, Kulwa K . Prevalence and awareness of obesity among people of different age groups in educational institutions in Morogoro, Tanzania. East Afr Med J. 2005; 80(2):68-72. DOI: 10.4314/eamj.v80i2.8648. View

Martorell R, Khan L, Hughes M, Grummer-Strawn L . Obesity in women from developing countries. Eur J Clin Nutr. 2000; 54(3):247-52. DOI: 10.1038/sj.ejcn.1600931. View

10.

Shuter J, Chang C, Klein R . Prevalence and predictive value of overweight in an urban HIV care clinic. J Acquir Immune Defic Syndr. 2001; 26(3):291-7. DOI: 10.1097/00042560-200103010-00013. View

11.

Crum-Cianflone N, Poehlman Roediger M, Eberly L, Headd M, Marconi V, Ganesan A . Increasing rates of obesity among HIV-infected persons during the HIV epidemic. PLoS One. 2010; 5(4):e10106. PMC: 2856157. DOI: 10.1371/journal.pone.0010106. View

12.

Villamor E, Msamanga G, Urassa W, Petraro P, Spiegelman D, Hunter D . Trends in obesity, underweight, and wasting among women attending prenatal clinics in urban Tanzania, 1995-2004. Am J Clin Nutr. 2006; 83(6):1387-94. DOI: 10.1093/ajcn/83.6.1387. View

13.

Fox C, Larson M, Leip E, Culleton B, Wilson P, Levy D . Predictors of new-onset kidney disease in a community-based population. JAMA. 2004; 291(7):844-50. DOI: 10.1001/jama.291.7.844. View

14.

Wilson P, DAgostino R, Levy D, Belanger A, Silbershatz H, Kannel W . Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97(18):1837-47. DOI: 10.1161/01.cir.97.18.1837. View

15.

Bonadonna R, Groop L, Kraemer N, Ferrannini E, Del Prato S, DeFronzo R . Obesity and insulin resistance in humans: a dose-response study. Metabolism. 1990; 39(5):452-9. DOI: 10.1016/0026-0495(90)90002-t. View

16.

Tang A, Jacobson D, Spiegelman D, Knox T, Wanke C . Increasing risk of 5% or greater unintentional weight loss in a cohort of HIV-infected patients, 1995 to 2003. J Acquir Immune Defic Syndr. 2005; 40(1):70-6. DOI: 10.1097/01.qai.0000159627.54149.2e. View

17.

Spiegelman D, Hertzmark E . Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol. 2005; 162(3):199-200. DOI: 10.1093/aje/kwi188. View

18.

Liu E, Spiegelman D, Semu H, Hawkins C, Chalamilla G, Aveika A . Nutritional status and mortality among HIV-infected patients receiving antiretroviral therapy in Tanzania. J Infect Dis. 2011; 204(2):282-90. DOI: 10.1093/infdis/jir246. View

19.

Masters R, Reither E, Powers D, Yang Y, Burger A, Link B . The impact of obesity on US mortality levels: the importance of age and cohort factors in population estimates. Am J Public Health. 2013; 103(10):1895-901. PMC: 3780738. DOI: 10.2105/AJPH.2013.301379. View

20.

Serwadda D, Mugerwa R, Sewankambo N, Lwegaba A, Carswell J, Kirya G . Slim disease: a new disease in Uganda and its association with HTLV-III infection. Lancet. 1985; 2(8460):849-52. DOI: 10.1016/S0140-6736(85)90122-9. View